IBOV 173,714.08 ▼ 0.06% IPSA 10,886.14 ▼ 0.56% IPC MEX 66,615.43 ▲ 0.39% MERVAL 3,199,934 ▲ 0.46% COLCAP 2,298.34 ▲ 0.58% BVL PERÚ 57,220.16 — — USD/BRL5.11▲ 0.19% USD/MXN17.53▲ 0.59% USD/CLP931.20▲ 0.67% USD/COP3,251▲ 0.61% USD/PEN3.39▲ 0.21% USD/ARS1,478▲ 0.17% USD/UYU40.23▲ 1.74% USD/PYG6,032▲ 1.81% USD/BOB10.65▲ 4.37% USD/DOP58.24▲ 1.37% USD/CRC446.12▲ 1.44% USD/GTQ7.62▲ 2.73% USD/HNL26.73▲ 1.94% USD/NIO36.62▲ 0.34% USD/VES730.65▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 0.87% USD/TTD6.74▲ 1.70% EUR/BRL5.84▲ 0.16% BRENT 88.10 ▲ 4.59% WTI 81.78 ▲ 3.58% IRON ORE 161.91 — — COPPER 6.27 ▼ 0.49% GOLD 4,019 ▲ 0.83% SILVER 56.33 ▲ 0.77% SOY 1,203 ▲ 0.67% CORN 467.50 ▲ 5.89% WHEAT 682.75 ▲ 1.19% COFFEE 304.70 ▼ 5.17% SUGAR 14.82 ▲ 2.63% ORANGE JUICE 139.35 ▲ 4.15% COTTON 78.93 ▲ 1.60% COCOA 5,753 ▲ 10.30% BEEF 220.70 ▼ 2.81% CATTLE 339.35 ▼ 2.09% LITHIUM 68.38 ▼ 0.70% PETR4 40.90 ▲ 2.53% VALE3 72.94 ▼ 0.05% ITUB4 41.96 ▼ 1.39% BBDC4 18.29 ▼ 0.65% ABEV3 15.63 ▲ 0.19% BBAS3 20.49 ▼ 1.30% B3SA3 15.20 ▼ 1.23% WEGE3 43.63 ▲ 0.32% PRIO3 57.85 ▲ 1.87% SUZB3 41.93 ▲ 0.55% RENT3 38.23 ▼ 1.62% AZZA3 18.59 ▲ 0.32% CSAN3 3.84 ▼ 1.03% RAIZ4 0.29 — 0.00% PCAR3 2.60 ▲ 0.39% GMAT3 3.88 ▼ 1.02% PSSA3 55.14 ▼ 0.14% CVCB3 1.22 ▼ 9.63% POSI3 3.80 ▼ 2.06% SLCE3 13.53 ▼ 0.59% NATU3 8.55 ▼ 0.12% BRKM5 6.19 ▲ 1.48% RANI3 7.95 ▼ 1.61% CSNA3 5.05 ▼ 0.98% CMIN3 5.33 ▼ 2.20% USIM5 8.23 ▲ 4.18% GGBR4 24.04 ▲ 0.54% ENEV3 25.68 ▼ 1.04% CPFE3 46.87 ▼ 0.68% CMIG4 11.12 ▲ 0.27% EQTL3 39.50 ▼ 0.88% LREN3 13.42 ▼ 1.69% VIVT3 35.52 ▲ 0.14% RAIL3 13.70 ▼ 1.65% KLABIN 17.58 ▲ 1.27% RAIA DROGASIL 18.55 ▲ 0.16% RDOR3 35.78 ▼ 0.25% HAPV3 11.38 ▲ 3.93% FLRY3 16.59 ▲ 1.04% SMTO3 15.45 ▼ 1.72% UGPA3 32.07 ▲ 0.25% VBBR3 34.92 ▲ 1.60% BBSE3 41.12 ▼ 0.15% BPAC11 56.18 ▼ 0.72% CURY3 30.67 ▼ 1.98% AERI3 2.02 — 0.00% VIVARA 22.44 ▼ 3.90% COMPASS 24.88 ▼ 0.12% VAMOS 3.17 ▲ 0.32% SANB11 26.65 ▼ 0.67% ASAI3 8.50 ▼ 0.70% SBSP3 29.22 ▼ 0.27% WALMEX 49.52 ▼ 0.08% GMEXICO 200.05 ▲ 0.41% FEMSA 225.68 ▲ 0.28% CEMEX 22.69 ▼ 0.40% GFNORTE 181.34 ▲ 0.53% BIMBO 58.00 ▲ 0.14% TELEVISA 9.57 ▲ 0.63% AMX 23.00 ▲ 0.97% GAP 386.00 ▼ 1.47% ASUR 279.71 ▼ 0.44% OMA 230.06 ▼ 1.30% KOF 181.10 ▲ 1.20% GRUMA 287.32 ▲ 0.34% KIMBER 38.67 ▼ 0.28% SQM-B 65,450 ▼ 0.91% COPEC 6,250 ▲ 2.02% BSANTANDER 77.00 ▼ 1.48% FALABELLA 5,835 ▼ 0.31% ENELAM 84.04 ▼ 0.90% CENCOSUD 1,995 ▼ 0.50% CMPC 1,070 ▼ 0.37% BANCO CHILE 188.50 ▼ 0.20% LATAM AIR 24.76 ▼ 2.52% YPF 77,900 ▲ 2.40% GGAL 7,860 ▼ 0.06% PAMPA 5,170 ▲ 1.17% TXAR 665.00 ▲ 0.45% ALUAR 949.50 ▲ 1.01% TGS 9,370 ▼ 0.16% CEPU 2,264 ▲ 0.18% MIRGOR 16,875 ▲ 0.75% COME 43.84 ▼ 1.39% LOMA NEGRA 3,535 ▼ 0.63% BYMA 299.00 ▼ 0.83% TELECOM ARG 4,150 ▼ 0.72% ECOPETROL 16.09 ▲ 1.84% BANCOLOMBIA 80.41 ▲ 1.18% GRUPO AVAL 4.92 ▼ 1.01% CREDICORP 390.70 ▲ 0.84% SOUTHERN COPPER 172.48 ▼ 1.81% BUENAVENTURA 30.24 ▲ 0.23% MERCADOLIBRE 1,814 ▼ 2.34% NUBANK 13.59 ▼ 1.45% XP 16.67 ▼ 0.06% PAGSEGURO 9.04 ▼ 1.20% STONE 11.15 ▼ 0.45% GLOBANT 32.23 ▲ 0.09% TECNOGLASS 46.48 ▼ 0.75% GAP AIRPORT 220.91 ▼ 1.94% ASUR 279.71 ▼ 0.44% OMA AIRPORT 105.31 ▼ 1.77% AMX ADR 26.27 ▲ 0.50% FEMSA ADR 129.02 ▼ 0.36% CEMEX ADR 12.98 ▼ 0.92% PETROBRAS ADR 17.97 ▲ 2.86% VALE ADR 14.19 ▼ 0.21% ITAU ADR 8.21 ▼ 1.14% SANTANDER BR 5.24 ▼ 1.04% AMBEV ADR 3.03 ▼ 0.66% CSN 0.99 ▼ 0.89% GERDAU 4.73 ▲ 0.11% LATAM ADR 52.56 ▼ 1.17% BTC 64,085 ▲ 0.29% ETH 1,845 ▲ 0.19% SOL 74.94 ▼ 0.10% XRP 1.09 ▼ 0.03% BNB 570.42 ▲ 0.47% ADA 0.16 ▼ 1.05% DOGE 0.07 ▼ 0.39% AVAX 6.56 ▼ 0.30% LINK 8.31 ▲ 0.68% DOT 0.83 ▼ 1.87% LTC 46.31 ▲ 2.58% BCH 220.36 ▲ 0.29% TRX 0.32 ▲ 0.09% XLM 0.19 ▲ 0.77% HBAR 0.07 ▲ 1.04% NEAR 1.92 ▼ 0.60% ATOM 1.49 ▼ 1.22% AAVE 88.95 ▼ 1.12% SELIC 14.25% EMBRAER 81.75 ▼ 0.02% EMBRAER ADR 64.09 ▼ 0.44% JBS 11.91 ▼ 1.00% JBS BDR 60.20 ▼ 2.11% MBRF3 15.03 ▼ 1.70% MBRFY 2.90 ▼ 1.02% INTER 5.37 ▼ 3.07% EGX 52,928 ▲ 0.70% USD/ZAR16.48— 0.00% USD/NGN1,378▼ 0.20% NIKKEI 64,141 ▼ 4.03% CSI300 4,529 ▼ 3.60% HSI 24,562 ▼ 1.78% NIFTY 24,334 ▲ 1.09% KOSPI 6,821 ▼ 6.37% JCI 6,176 ▲ 1.10% USD/JPY162.35▼ 0.03% USD/CNY6.78▲ 0.05% DAX 24,831 ▼ 0.34% CAC 8,339 ▼ 0.47% FTSE 10,600 ▲ 0.27% MIB 51,882 ▼ 0.94% IBEX 19,217 ▼ 0.45% STOXX 641.53 ▼ 0.34% EUR/USD1.14▲ 0.04% GBP/USD1.35▼ 0.66% SPX 7,458 ▼ 1.01% DJI 52,146 ▼ 0.77% NDX 28,593 ▼ 1.49% RUT 2,962 ▼ 0.42% TSX 35,264 ▼ 0.22% VIX 18.77 ▲ 12.19% USD/CAD1.40— 0.00% US10Y 4.5410 ▼ 0.61% IBOV 173,714.08 ▼ 0.06% IPSA 10,886.14 ▼ 0.56% IPC MEX 66,615.43 ▲ 0.39% MERVAL 3,199,934 ▲ 0.46% COLCAP 2,298.34 ▲ 0.58% BVL PERÚ 57,220.16 — — USD/BRL 5.11 ▲ 0.19% USD/MXN 17.53 ▲ 0.59% USD/CLP 931.20 ▲ 0.67% USD/COP 3,251 ▲ 0.61% USD/PEN 3.39 ▲ 0.21% USD/ARS 1,478 ▲ 0.17% USD/UYU 40.23 ▲ 1.74% USD/PYG 6,032 ▲ 1.81% USD/BOB 10.65 ▲ 4.37% USD/DOP 58.24 ▲ 1.37% USD/CRC 446.12 ▲ 1.44% USD/GTQ 7.62 ▲ 2.73% USD/HNL 26.73 ▲ 1.94% USD/NIO 36.62 ▲ 0.34% USD/VES 730.65 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 0.36% USD/TTD 6.74 ▲ 1.17% EUR/BRL 5.84 ▲ 0.16% BRENT 88.10 ▲ 4.59% WTI 81.78 ▲ 3.58% IRON ORE 161.91 — — COPPER 6.27 ▼ 0.49% GOLD 4,019 ▲ 0.83% SILVER 56.33 ▲ 0.77% SOY 1,203 ▲ 0.67% CORN 467.50 ▲ 5.89% WHEAT 682.75 ▲ 1.19% COFFEE 304.70 ▼ 5.17% SUGAR 14.82 ▲ 2.63% ORANGE JUICE 139.35 ▲ 4.15% COTTON 78.93 ▲ 1.60% COCOA 5,753 ▲ 10.30% BEEF 220.70 ▼ 2.81% CATTLE 339.35 ▼ 2.09% LITHIUM 68.38 ▼ 0.70% PETR4 40.90 ▲ 2.53% VALE3 72.94 ▼ 0.05% ITUB4 41.96 ▼ 1.39% BBDC4 18.29 ▼ 0.65% ABEV3 15.63 ▲ 0.19% BBAS3 20.49 ▼ 1.30% B3SA3 15.20 ▼ 1.23% WEGE3 43.63 ▲ 0.32% PRIO3 57.85 ▲ 1.87% SUZB3 41.93 ▲ 0.55% RENT3 38.23 ▼ 1.62% AZZA3 18.59 ▲ 0.32% CSAN3 3.84 ▼ 1.03% RAIZ4 0.29 — 0.00% PCAR3 2.60 ▲ 0.39% GMAT3 3.88 ▼ 1.02% PSSA3 55.14 ▼ 0.14% CVCB3 1.22 ▼ 9.63% POSI3 3.80 ▼ 2.06% SLCE3 13.53 ▼ 0.59% NATU3 8.55 ▼ 0.12% BRKM5 6.19 ▲ 1.48% RANI3 7.95 ▼ 1.61% CSNA3 5.05 ▼ 0.98% CMIN3 5.33 ▼ 2.20% USIM5 8.23 ▲ 4.18% GGBR4 24.04 ▲ 0.54% ENEV3 25.68 ▼ 1.04% CPFE3 46.87 ▼ 0.68% CMIG4 11.12 ▲ 0.27% EQTL3 39.50 ▼ 0.88% LREN3 13.42 ▼ 1.69% VIVT3 35.52 ▲ 0.14% RAIL3 13.70 ▼ 1.65% KLABIN 17.58 ▲ 1.27% RAIA DROGASIL 18.55 ▲ 0.16% RDOR3 35.78 ▼ 0.25% HAPV3 11.38 ▲ 3.93% FLRY3 16.59 ▲ 1.04% SMTO3 15.45 ▼ 1.72% UGPA3 32.07 ▲ 0.25% VBBR3 34.92 ▲ 1.60% BBSE3 41.12 ▼ 0.15% BPAC11 56.18 ▼ 0.72% CURY3 30.67 ▼ 1.98% AERI3 2.02 — 0.00% VIVARA 22.44 ▼ 3.90% COMPASS 24.88 ▼ 0.12% VAMOS 3.17 ▲ 0.32% SANB11 26.65 ▼ 0.67% ASAI3 8.50 ▼ 0.70% SBSP3 29.22 ▼ 0.27% WALMEX 49.52 ▼ 0.08% GMEXICO 200.05 ▲ 0.41% FEMSA 225.68 ▲ 0.28% CEMEX 22.69 ▼ 0.40% GFNORTE 181.34 ▲ 0.53% BIMBO 58.00 ▲ 0.14% TELEVISA 9.57 ▲ 0.63% AMX 23.00 ▲ 0.97% GAP 386.00 ▼ 1.47% ASUR 279.71 ▼ 0.44% OMA 230.06 ▼ 1.30% KOF 181.10 ▲ 1.20% GRUMA 287.32 ▲ 0.34% KIMBER 38.67 ▼ 0.28% SQM-B 65,450 ▼ 0.91% COPEC 6,250 ▲ 2.02% BSANTANDER 77.00 ▼ 1.48% FALABELLA 5,835 ▼ 0.31% ENELAM 84.04 ▼ 0.90% CENCOSUD 1,995 ▼ 0.50% CMPC 1,070 ▼ 0.37% BANCO CHILE 188.50 ▼ 0.20% LATAM AIR 24.76 ▼ 2.52% YPF 77,900 ▲ 2.40% GGAL 7,860 ▼ 0.06% PAMPA 5,170 ▲ 1.17% TXAR 665.00 ▲ 0.45% ALUAR 949.50 ▲ 1.01% TGS 9,370 ▼ 0.16% CEPU 2,264 ▲ 0.18% MIRGOR 16,875 ▲ 0.75% COME 43.84 ▼ 1.39% LOMA NEGRA 3,535 ▼ 0.63% BYMA 299.00 ▼ 0.83% TELECOM ARG 4,150 ▼ 0.72% ECOPETROL 16.09 ▲ 1.84% BANCOLOMBIA 80.41 ▲ 1.18% GRUPO AVAL 4.92 ▼ 1.01% CREDICORP 390.70 ▲ 0.84% SOUTHERN COPPER 172.48 ▼ 1.81% BUENAVENTURA 30.24 ▲ 0.23% MERCADOLIBRE 1,814 ▼ 2.34% NUBANK 13.59 ▼ 1.45% XP 16.67 ▼ 0.06% PAGSEGURO 9.04 ▼ 1.20% STONE 11.15 ▼ 0.45% GLOBANT 32.23 ▲ 0.09% TECNOGLASS 46.48 ▼ 0.75% GAP AIRPORT 220.91 ▼ 1.94% ASUR 279.71 ▼ 0.44% OMA AIRPORT 105.31 ▼ 1.77% AMX ADR 26.27 ▲ 0.50% FEMSA ADR 129.02 ▼ 0.36% CEMEX ADR 12.98 ▼ 0.92% PETROBRAS ADR 17.97 ▲ 2.86% VALE ADR 14.19 ▼ 0.21% ITAU ADR 8.21 ▼ 1.14% SANTANDER BR 5.24 ▼ 1.04% AMBEV ADR 3.03 ▼ 0.66% CSN 0.99 ▼ 0.89% GERDAU 4.73 ▲ 0.11% LATAM ADR 52.56 ▼ 1.17% BTC 64,085 ▲ 0.29% ETH 1,845 ▲ 0.19% SOL 74.94 ▼ 0.10% XRP 1.09 ▼ 0.03% BNB 570.42 ▲ 0.47% ADA 0.16 ▼ 1.05% DOGE 0.07 ▼ 0.39% AVAX 6.56 ▼ 0.30% LINK 8.31 ▲ 0.68% DOT 0.83 ▼ 1.87% LTC 46.31 ▲ 2.58% BCH 220.36 ▲ 0.29% TRX 0.32 ▲ 0.09% XLM 0.19 ▲ 0.77% HBAR 0.07 ▲ 1.04% NEAR 1.92 ▼ 0.60% ATOM 1.49 ▼ 1.22% AAVE 88.95 ▼ 1.12% SELIC 14.25% EMBRAER 81.75 ▼ 0.02% EMBRAER ADR 64.09 ▼ 0.44% JBS 11.91 ▼ 1.00% JBS BDR 60.20 ▼ 2.11% MBRF3 15.03 ▼ 1.70% MBRFY 2.90 ▼ 1.02% INTER 5.37 ▼ 3.07% EGX 52,928 ▲ 0.70% USD/ZAR 16.48 ▲ 0.63% USD/NGN 1,378 ▲ 0.02% NIKKEI 64,141 ▼ 4.03% CSI300 4,529 ▼ 3.60% HSI 24,562 ▼ 1.78% NIFTY 24,334 ▲ 1.09% KOSPI 6,821 ▼ 6.37% JCI 6,176 ▲ 1.10% USD/JPY 162.35 ▲ 0.01% USD/CNY 6.7768 ▲ 0.20% DAX 24,831 ▼ 0.34% CAC 8,339 ▼ 0.47% FTSE 10,600 ▲ 0.27% MIB 51,882 ▼ 0.94% IBEX 19,217 ▼ 0.45% STOXX 641.53 ▼ 0.34% EUR/USD 1.1446 ▲ 0.02% GBP/USD 1.3452 ▼ 0.21% SPX 7,458 ▼ 1.01% DJI 52,146 ▼ 0.77% NDX 28,593 ▼ 1.49% RUT 2,962 ▼ 0.42% TSX 35,264 ▼ 0.22% VIX 18.77 ▲ 12.19% USD/CAD 1.4020 ▼ 0.14% US10Y 4.5410 ▼ 0.61%
since 2009
Saturday, July 18, 2026

Covid-19: Updated count of reported injuries and deaths after vaccines in EU member states (September 11)

By · September 15, 2021 · 4 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – EudraVigilance, the European database for reporting adverse drug reactions, had collected, as of September 11, 24,526 reports of deaths and 2,317,495 reports of injuries (half of them serious) from people who received some of the four experimental injections currently licensed within the member countries of the European Union.

Read also: Check out our coverage on Dissenter’s Voice

In the previous report, dated August 28, the number of reported deaths was 23,252, and the number of injuries was 2,189,537.

Update on the count of reported injuries and deaths following Covid vaccines in EU member states (September 11)
Update on the count of reported injuries and deaths following Covid vaccines in EU member states (September 11)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

EudraVigilance was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects. These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and pharmaceutical companies holding marketing authorizations (licenses).

Through September 11, 2021, their report lists 24,526 deaths and 2,317,495 injuries following injections with any of the four currently approved experimental vaccines.

MODERNA – COVID-19 mRNA (CX-024414)
PFIZER-BIONTECH – COVID-19 mRNA
ASTRAZENECA – COVID-19 (CHADOX1 NCOV-19)
JANSSEN – COVID-19 (AD26.COV2.S )

Of the total number of recorded injuries, almost half of them (1,126,869) remain serious injuries.

It should be noted that, just as not all reported deaths and injuries need necessarily be vaccine-related, it is well known that these reports represent a very minimal amount of the actual cases, as most death and injury events are not being reported.

We recommend reading the analysis made by Laurent Mucchielli, research director of the French National Center for Scientific Research (CNRS), who reviewed several databases of adverse event reports on Covid vaccines worldwide and ended up launching a direct warning to all: “We are facing an unprecedented mortality, and a moratorium on this vaccination must be put in place”.

SUMMARIZED DATA EUDRAVIGILANCE AS PER SEPTEMBER 11, 2021

Total reactions for the Pfizer/BioNTech vaccine:

11,711 deaths and 980,474 injuries.

  • 26,634 Blood and lymphatic disorders, incl. 156 death
  • 26,940 Cardiac disorders incl. 1,745 deaths
  • 253 Congenital, familial, and genetic disorders, incl. 21 deaths
  • 13,005 Hearing and labyrinth disorders, incl. 9 deaths
  • 728 Endocrine disorders, incl. 5 deaths
  • 15,314 Eye disorders incl. 28 deaths
  • 87,239 Gastrointestinal disorders incl. 489 deaths
  • 256,117 General disorders and administration site disorders, incl. 3,330 deaths
  • 1,098 Hepatobiliary disorders incl. 55 deaths
  • 10,351 Immune system disorders incl. 64 deaths
  • 32,834 Infections and infestations incl. 1,141 deaths
  • 12,714 Injuries, poisoning, and procedural complications, incl. 179 deaths
  • 24,765 Investigations incl. 368 deaths
  • 7,178 Disorders of metabolism and nutrition incl. 210 deaths
  • 130,077 Musculoskeletal and connective tissue disorders incl. 149 deaths
  • 757 Benign, malignant, malignant, and unspecified neoplasms (including cysts and polyps) incl. 67 deaths
  • 173,079 Nervous system disorders, incl. 1278 deaths
  • 1,211 Pregnancy, puerperium, and perinatal conditions, incl. 36 deaths
  • 168 Product problems incl. 1 death
  • 17,756 Psychiatric disorders incl. 156 deaths
  • 3,348 Renal and urinary disorders incl. 198 deaths
  • 19,084 Reproductive system and breast disorders, incl. 3 deaths
  • 43.232 Respiratory, thoracic and mediastinal disorders, incl. 1376 deaths
  • 47,012 Skin and subcutaneous tissue disorders, incl. 105 deaths
  • 1,805 Social circumstances incl. 14 deaths
  • 887 Medical and surgical procedures incl. 31 deaths
  • 26,888 Vascular disorders incl. 497 deaths

Total reactions for the Moderna vaccine
6,358 deaths and 281,505 injuries

  • 5,465 Blood and lymphatic system disorders, incl. 59 deaths
  • 8,364 Cardiac disorders incl. 687 deaths
  • 113 Congenital, familial, and genetic disorders, incl. 2 deaths
  • 3,466 Hearing and labyrinth disorders, incl. 1 death
  • 221 Endocrine disorders incl. 2 deaths
  • 4,302 Eye disorders incl. 18 deaths
  • 24,595 Gastrointestinal disorders incl. 237 deaths
  • 75,804 General disorders and administration site disorders, incl. 2,461 deaths
  • 458 Hepatobiliary disorders incl. 24 deaths
  • 2,485 Immune system disorders, incl. 11 deaths
  • 8,436 Infections and infestations incl. 416 deaths
  • 6,013 Injuries, intoxication, and procedural complications, incl. 121 deaths
  • 5,460 Investigations incl. 120 deaths
  • 2,693 Disorders of metabolism and nutrition incl. 145 deaths
  • 35,728 Musculoskeletal and connective tissue disorders incl. 129 deaths
  • 333 Benign, malignant, malignant, and unspecified neoplasms (including cysts and polyps) incl. 37 deaths
  • 49,722 Nervous system disorders, incl. 650 deaths
  • 538 Pregnancy, puerperium, and perinatal conditions, incl. 6 deaths
  • 59 Product issues incl. 1 death
  • 5,316 Psychiatric disorders, incl. 110 deaths
  • 1,632 Renal and urinary disorders incl. 107 deaths
  • 3,558 Reproductive system and breast disorders incl. 3 deaths
  • 12,150 Respiratory, thoracic, and mediastinal disorders incl. 614 deaths
  • 15,102 Disorders of the skin and subcutaneous tissue, incl. 57 deaths
  • 1,188 Social circumstances incl. 25 deaths
  • 905 Medical and surgical procedures incl. 69 deaths
  • 7,399 Vascular disorders incl. 246 deaths

Total reactions for Oxford/AstraZeneca vaccine:

5,254 deaths and 980,909 injuries.

  • 11,826 Blood and lymphatic system disorders, incl. 221 deaths
  • 16,641 Cardiac disorders incl. 603 deaths
  • 158 Familial congenital and genetic disorders, incl. 5 deaths
  • 11,541 Ear and labyrinth disorders, incl. 1 death
  • 504 Endocrine disorders incl. 4 deaths
  • 17,332 Eye disorders incl. 22 deaths
  • 96,191 Gastrointestinal disorders incl. 270 deaths
  • 257,766 General disorders and administration site disorders incl. 1278 deaths
  • 831 Hepatobiliary disorders incl. 51 deaths
  • 3,987 Immune system disorders incl. 23 deaths
  • 24,674 Infections and infestations incl. 330 deaths
  • 11,183 Poisoning due to injuries and procedural complications, incl. 141 deaths
  • 21,578 Investigations incl. 121 deaths
  • 11,626 Disorders of metabolism and nutrition incl. 73 deaths
  • 148,195 Musculoskeletal and connective tissue disorders incl. 74 deaths
  • 510 Benign malignant and unspecified neoplasms (including cysts and polyps) incl. 16 deaths
  • 204,423 Nervous system disorders incl. 840 deaths
  • 439 Pregnancy, puerperium, and perinatal conditions incl. 11 deaths
  • 158 Product problems incl. 1 death
  • 18,501 Psychiatric disorders incl. 47 deaths
  • 3,639 Renal and urinary disorders incl. 48 deaths
  • 12,993 Reproductive system and breast disorders, incl. 2 deaths
  • 34,557 Respiratory, thoracic, and mediastinal disorders incl. 629 deaths
  • 45,140 Skin and subcutaneous tissue disorders, incl. 36 deaths
  • 1,291 Social circumstances, incl. 6 deaths
  • 1,142 Medical and surgical procedures, incl. 22 deaths
  • 24,083 Vascular disorders incl. 379 deaths

Total reactions for Johnson & Johnson vaccine:
1,203 deaths and 74,607 injuries.

  • 690 Blood and lymphatic system disorders, incl. 31 deaths
  • 1,201 Cardiac disorders incl. 120 deaths
  • 25 Congenital, familial and genetic disorders
  • 560 Disorders of the ear and labyrinth, incl. 1 death
  • 42 Endocrine disorders incl. 1 death
  • 1,006 Ocular disorders incl. 5 deaths
  • 6,822 Gastrointestinal disorders incl. 56 deaths
  • 19,539 General disorders and administration site disorders incl. 303 deaths
  • 96 Hepatobiliary disorders incl. 9 deaths
  • 302 Immune system disorders, incl. 7 deaths
  • 1,679 Infections and infestations incl. 66 deaths
  • 694 Injuries, intoxication, and procedural complications, incl. 16 deaths
  • 3,861 Investigations incl. 72 deaths
  • 431 Disorders of metabolism and nutrition, incl. 26 deaths
  • 11,861 Disorders of musculoskeletal and connective tissue, incl. 30 deaths
  • 31 Benign, malignant, and unspecified neoplasms (including cysts and polyps) incl. 2 deaths
  • 15493 Nervous system disorders incl. 142 deaths
  • 26 Pregnancy, puerperium, and perinatal conditions incl. 1 death
    20 Product problems
  • 988 Psychiatric disorders incl. 11 deaths
  • 280 Renal and urinary disorders incl. 11 deaths
  • 863 Reproductive system and breast disorders, incl. 4 deaths
  • 2,629 Respiratory, thoracic, and mediastinal disorders incl. 136 deaths
  • 2,296 Skin and subcutaneous tissue disorders, incl. 5 deaths
  • 212 Social circumstances incl. 4 deaths
  • 546 Medical and surgical procedures incl. 38 deaths
  • 2,414 Vascular disorders incl. 106 deaths

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.